GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-3,906 Cr | ₹-77 Cr | ₹-520 Cr | ₹-442 Cr | ₹-445 Cr |
What is the latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-3,906 Cr |
Mar2023 | ₹-77 Cr |
Mar2022 | ₹-520 Cr |
Mar2021 | ₹-442 Cr |
Mar2020 | ₹-445 Cr |
How is Cash Flow from Financing Activities of GLENMARK PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-3,906 Cr | Negative | |
Mar2023 | ₹-77 Cr | Negative | |
Mar2022 | ₹-520 Cr | Negative | |
Mar2021 | ₹-442 Cr | Negative | |
Mar2020 | ₹-445 Cr | - |
Compare Cash Flow from Financing Activities of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹57,891.9 Cr | -4.8% | 10.2% | 43.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -4.8% |
10.2% |
43.7% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses